Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Beate Timmermann, Ken Brown et al.|European Journal of Cancer|2019Cited by 724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa Marina, Lisa A. Teot, Sigbjørn Smeland et al.|The Lancet Oncology|2016Cited by 537
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcomaVincent Poon, Richard Görlick, Michael Roth et al.|Clinical Sarcoma Research|2015Cited by 64
The Care of Children With Cancer During the COVID-19 PandemicDaniel C. Moreira, Douglas S. Hawkins, Gerard Millen et al.|American Society of Clinical Oncology Educational Book|2021Cited by 31
Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).Alice A. Lee, D. Williams Parsons, Alexander J. Chou et al.|Journal of Clinical Oncology|2023Cited by 18